Anticorpi e altri reagenti

L'anticorpo anti-GAPDH(6C5), l'anticorpo anti-IFITM-2 (A-6) (sc-373676), l'anticorpo anti-neuropilina (-286 H) (SC-5541), l'anticorpo anti-fosfo-p38 (sc-17852-R) sono stati forniti da Santa Cruz Biotechnology (Santa Cruz, CA, USA). L'anticorpo anti- fosfo-Akt (9271) è stato fornito da Cell Signaling (Boston, MA, USA). Gli anticorpi anti- CD14 e anti-CD3 sono stati ottenuti dalla eBIOSCIENCE Il kit per Mouse IL-6 ELISA (88-

7064-88) è stato fornito da eBioscience, Inc. (San Diego, CA, Stati Uniti). L'inibitore di PI3K (PI3Ki) LY294002, e l'inibitore di p38 (MAPKi) SB203580 sono stati acquistati da Calbiochem (Darmstadt, Germania). Il kit Human Proteome Profiler Cytokine XL Kit è stato acquistato dalla R&D.

Bibliografia

BIBLIOGRAFIA

Ammirante M, Rosati A, Arra C, Basile A, Falco A, Festa M, Pascale M, d'Avenia M, Marzullo L, Belisario MA, De Marco M, Barbieri A, Giudice A, Chiappetta G, Vuttariello E, Monaco M, Bonelli P, Salvatore G, Di Benedetto M, Deshmane SL, Khalili K, Turco MC, Leone A. 2010. IKK {gamma} protein is a target of BAG3 regulatory activity in human tumor growth. Proc Natl Acad Sci U S A. 107, 7497-502.

Asea A, Kraeft SK, Kurt-Jones EA, Stevenson MA, Chen LB, Finberg RW, Koo GC, Calderwood SK. 2000. HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine. Nat Med. 6(4), 435-42.

Basile A, Zeppa R, Pasquino N, Arra C, Ammirante M, Festa M, Barbieri A, Giudice A, Pascale M, Turco MC, Rosati A. 2011. Exposure to 50 Hz electromagnetic field raises the levels of the anti-apoptotic protein BAG3 in melanoma cells, J Cell Physiol. 226, 2901-7.

Beere HM. 2005. Death versus survival: functional interaction between the apoptotic and stress-inducible heat shock protein pathways. J Clin Invest. 115, 2633- 9.

Ben Aicha S, Lessard J, Pelletier M, Fournier A, Calvo E, Labrie C. 2007. Transcriptional profiling of genes that are regulated by the endoplasmic reticulum- bound transcription factor AIbZIP/CREB3L4 in prostate cells. Physiol Genomic. 31, 295–305.

Bernatchez PN, Rollin S, Soker S, et al. 2002. Relative effects of VEGF-A and VEGF-C on endothelial cells proliferation, migration and PAF synthesis: role of neuropilin-1. J Cell Biochem. 85, 629 – 39.

Bissell MJ, Radisky D. 2001. Putting tumours in context. Nat Rev Cancer. 1(1), 46-54.

Bruno AP, Festa M, Dal Piaz F, Rosati A, Turco MC, Giuditta A. 2008. Identification of a synaptosome-associated form of BAG3 protein. Cell Cycle. 7, 3104–3105.

Carra S. 2009a. The stress-inducible HspB8-Bag3 complex induces the eIF2alpha kinase pathway: implications for protein quality control and viral factory degradation?. Autophagy. 5. 428–429.

Carra S, Brunsting JF, Lambert H, Landry J, Kampinga HH. 2009b. HspB8 participates in protein quality control by a non-chaperone-like mechanism that requires eIF2 {alpha} phosphorylation. J Biol Chem. 284, 5523–5532.

Bibliografia

Cesaro E, Montano G, Rosati A, Crescitelli R, Izzo P, Turco MC, Costanzo P. 2010. WT1 protein is a transcriptional activator of the antiapoptotic bag3 gene. Leukemia. 24(6), 1204-6.

Chen YA, Scheller RH. 2001. SNARE-mediated membrane fusion, Nat Rev Mol Cell Biol. 2, 98-106.

Chiappetta G, Ammirante M, Basile A, Rosati A, Festa M, Monaco M, et al. 2007. The antiapoptotic protein BAG3 is expressed in thyroid carcinomas and modulates apoptosis mediated by tumor necrosis factor-related apoptosis-inducing ligand. The Journal of Clinical Endocrinology & Metabolism. 92,1159-63.

Colotta Francesco, Paola Allavena, Antonio Sica, Cecilia Garlanda and Alberto Mantovani. 2009. Cancer-related Inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis. 30(7), 1073-1081.

Coulson M, Robert S, Saint R. 2005. Drosophila starving encodes a tissue- specific BAG-domain protein required for larval food uptake. Genetics. 171, 1799- 812.

Davies LC, Rosas M, Jenkins SJ, Liao CT, Scurr MJ, Brombacher F, Fraser DJ, Allen JE, Jones SA, Taylor PR. 2013. Distinct bone marrow-derived and tissue- resident macrophage lineages proliferate at key stages during inflammation. Nat Commun. 4, 1886.

De Marco M, Falco A, Basile A, Rosati A, Festa M, d'Avenia M, Pascale M, Dal Piaz F, Bisogni R, Barcaroli D, Coppola G, Piscione F, Gigantino A, Citro R, De Rosa R, Vitulano G, Virtuoso N, Manganelli F, Palermo E, Siano F, Rosato G, Hahne M, Tiberti C, De Laurenzi V, Turco MC. 2013. Detection of soluble BAG3 and anti- BAG3 antibodies in patients with chronic heart failure. Cell Death Dis. 4, e495.

De Marzo AM, Marchi VL, Epstein JI, Nelson WG. 1999. Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis. Am J Pathol. 155(6):1985-92.

Diamond MS, Farzan M. 2013. The broad-spectrum antiviral functions of IFIT and IFITM proteins. Nat Rev Immunol. 13(1):46-57.

Doong H, Rizzo K, Fang S, Kulpa V, Weissman AM, Kohn EC. 2003. CAR- 1/BAG-3 abrogates heat shock protein-70 chaperone complex-mediated protein degradation: accumulation of poly-ubiquitinated HSP90 client proteins, J Biol Chem, 278, 28490-500.

Dreiza CM, Komalavilas P, Furnish EJ, Flynn CR, Sheller MR, Smoke CC et al. 2010. The small heat shock protein, HSPB6, in muscle function and disease. Cell Stress Chaperones. 15, 1-11.

Bibliografia

Du ZX, Meng X, Zhang HY, Guan Y, Wang HQ. 2008. Caspase-dependent cleavage of BAG3 in proteasome inhibitors-induced apoptosis in thyroid cancer cells. Biochem Biophys Res Commun. 369, 894–898.

Falco A, Rosati A, Festa M, Basile A, De Marco M, d'Avenia M, Pascale M, Dal Piaz F, Tavano F, Di Mola FF, di Sebastiano P, Berloco PB, Nudo F, Caraglia M, Febbraro A, Barcaroli D, Scarpa A, Pezzilli R, De Laurenzi V, Turco MC. 2013. BAG3 is a novel serum biomarker for pancreatic adenocarcinomas. Am J Gastroenterol. 108(7), 1178-80.

Fan GC, Chu G, Kranias EG. 2005. Hsp20 and its cardioprotection. Trends Cardiovasc Med. 15,138–41.

Feeley E M et al. 2011. IFITM3 inhibits influenza A virus infection by preventing cytosolic entry, PLoS Pathog. 7, e1002337.

Festa M, Del Valle L, Franco R, Scognamiglio G, Khalili K, De Laurenzi L, et al. 2011. BAG3 protein is overexpressed in human glioblastoma and is a potential target for its therapy. Am J Pathol. 178, 2504-12.

Fontanella B, Birolo L, Infusini G, Cirulli C, Marzullo L, Pucci P, Turco MC, Tosco A. 2010. The co-chaperone BAG3 interacts with the cytosolic chaperonin CCT: new hints for actin folding. Int J Biochem Cell Biol. 42(5):641-50.

Franceschelli S, Rosati A, Lerose R, De Nicola S, Turco MC, Pascale M. 2008. Bag3 Gene Expression is Regulated by Heat Shock Factor 1. J. Cell. Physiol. 215, 575-7.

Fuchs M, Poirier DJ, Seguin SJ, Lambert H, Carra S, Charette SJ, et al. 2009. Identification of the key structural motifs involved in HspB8/HspB6-Bag3 interaction. Biochem J. 425, 245–55.

Fujiwara N, Kobayashi K 2005. Macrophages in inflammation. Curr. Drug Targets Inflamm. Allergy. 4, 281-6.

Gautier EL, Ivanov S, Lesnik P, Randolph GJ. 2013. Local apoptosis mediates clearance of macrophages from resolving inflammation in mice. Blood. 122(15), 2714-22.

Gentilella A, Passiatore G, Deshmane S, Turco MC, Khalili K. 2008. Activation of BAG3 by Egr-1 in response to FGF-2 in neuroblastoma cells. Oncogene. 28, 5011-18.

Hanahan D, Weinberg RA. 2000. The hallmarks of cancer. Cell. 100(1), 57- 70.

Bibliografia

Hansel DE, Wilentz RE, Yeo CJ, Schulick RD, Montgomery E, Maitra A. 2004. Expression of neuropilin-1 in high-grade dysplasia, invasive cancer, and metastases of the human gastrointestinal tract. Am J Surg Pathol. 28, 347–56.

Hickford D, Frankenberg S, Shaw G & Renfree M B. 2012. Evolution of vertebrate interferon inducible transmembrane proteins. BMC Genomics. 13, 155.

Hume DA. 2008. Differentiation and heterogeneity in the mononuclear phagocyte system. Mucosal Immunol. 1(6):432-41.

Iwasaki M, Homma S, Hishiya A, Dolezal SJ, Reed JC, Takayama S. 2007. BAG3 regulates motility and adhesion of epithelial cancer cells. Cancer Res. 67, 10252–10259.

Iwasaki M, Tanaka R, Hishiya A, Homma S, Reed JC, Takayama S. 2010. BAG3 directly associates with guanine nucleotide exchange factor of Rap1, PDZGEF2, and regulates cell adhesion. Biochem Biophys Res Commun. 400, 413– 418.

Jacobs AT, Marnett LJ. 2009. HSF1-mediated BAG3 expression attenuates apoptosis in 4-hydroxynonenal-treated colon cancer cells via stabilization of anti- apoptotic Bcl-2 proteins. J Biol Chem. 284, 9176–9183.

Jaffe, E. A. et al. 1989. IFN-α and IFN-γ induce the expression and synthesis of Leu 13 antigen by cultured human endothelial cells. J. Immunol. 143, 3961-3966.

Jung SE, Kim YK, Youn DY, Lim MH, Ko JH, Ahn YS et al. 2010. Down- modulation of Bis sensitizes cell death in C6 glioma cells induced by oxygen-glucose deprivation. Brain Res. 1349, 1-10.

Kassis JN, Guancial EA, Doong H, Virador V, Kohn EC. 2006. CAIR-1/BAG-3 modulates cell adhesion and migration by downregulating activity of focal adhesion proteins. Exp Cell Res. 312. 2962–2971.

Kassis JN, Virador VM, Guancial EA, Kimm D, Ho AS, Mishra M, et al. 2009. Genomic and phenotypic analysis reveals a key role for CCN1 (CYR61) in BAG3- modulated adhesion and invasion. J Pathol. 218, 495–504

Knowles HJ, Harris AL, 2007. Macrophages and the hypoxic tumour microenvironment. Front Biosci. 12, 4298-314.

Kumanogoh A, Kikutani H. 2013. Immunological functions of the neuropilins and plexins as receptors for semaphorins. Nat Rev Immunol. 13(11), 802-14.

Kuper H, Adami HO, Trichopoulos D. 2000. Infections as a major preventable cause of human cancer. J Intern Med. 248(3), 171-83.

Bibliografia

Lee MY, Kim SY, Choi JS, Choi YS, Jeon MH, Lee JH, et al. 2002. Induction of Bis, a Bcl-2-binding protein, in reactive astrocytes of the rat hippocampus following kainic acid-induced seizure. Exp Mol Med. 34, 167-71.

Lewin A R, Reid L E, McMahon M, Stark G R & Kerr I M. 1991. Molecular analysis of a human interferon-inducible gene family. Eur, J. Biochem. 199(2), 417- 423.

Li K, Markosyan RM, Zheng YM, Golfetto O, Bungart B, Li M, Ding S, He Y, Liang C, Lee JC, Gratton E, Cohen FS, Liu SL. 2013. IFITM proteins restrict viral membrane hemifusion, PLoS Pathog, 9(1), e1003124.

Li N, Du ZX, Zong ZH, Liu BQ, Li C, Zhang Q, Wang HQ. 2013. PKCδ- mediated phosphorylation of BAG3 at Ser187 site induces epithelial-mesenchymal transition and enhances invasiveness in thyroid cancer FRO cells. Oncogene. 32(38), 4539-48.

Liu P, Xu B, Li J, Lu H. 2009. BAG3 gene silencing sensitizes leukemic cells to Bortezomib-induced apoptosis. FEBS Lett. 583, 401–406.

Malhotra V. 2013. Unconventional protein secretion: an evolving mechanism. EMBO J. 32(12), 1660-4.

Mantovani A, Sica A. 2010. Macrophages, innate immunity and cancer: balance, tolerance and diversity. Curr Opin Immunol. 22(2), 231-7.

Mantovani, A. et al. 2008. Cancer-related inflammation. Nature. 454, 436- 444.

Matsui H, Asou H, Inaba T. 2007. Cytokines direct the regulation of Bim mRNA stability by heat-shock cognate protein 70. Mol Cell. 25, 99-112.

McCollum AK, Casagrande G, Kohn EC. 2009. Caught in the middle: the role of Bag3 in disease. Biochem J. 425(1), e1-3.

Moreau K, Luo S, Rubinsztein DC. 2010. Cytoprotective roles for autophagy. Curr Opin Cell Biol. 22(2):206-11.

Pagliuca MG, Lerose R, Cigliano S, Leone A. 2003. Regulation by heavy metals and temperature of the human BAG-3 gene, modulator of Hsp70 activity. FEBS Lett. 541, 11-5.

Parker MW, Xu P, Li X, Vander Kooi CW. 2012. Structural basis for selective vascular endothelial growth factor-A (VEGF-A) binding to neuropilin-1. J Biol Chem. 287(14), 11082-9.

Bibliografia

Perreira JM, Chin CR, Feeley EM, Brass AL. 2013. IFITMs restrict the replication of multiple pathogenic viruses. J Mol Biol. 425(24), 4937-55.

Prud'homme GJ, Glinka Y. 2012. Neuropilins are multifunctional coreceptors involved in tumor initiation, growth, metastasis and immunity. Oncotarget. 3(9), 921- 39.

Rabouille C1, Malhotra V, Nickel W. 2012. Diversity in unconventional protein secretion. J Cell Sci. 125(Pt 22), 5251-5.

Rebane A, Zimmermann M, Aab A, Baurecht H, Koreck A, Karelson M, Abram K, Metsalu T, Pihlap M, Meyer N, Fölster-Holst R, Nagy N, Kemeny L, Kingo K, Vilo J, Illig T, Akdis M, Franke A, Novak N, Weidinger S, Akdis CA. 2012. Mechanisms of IFN-γ-induced apoptosis of human skin keratinocytes in patients with atopic dermatitis. J Allergy Clin Immunol. 129(5), 1297-306.

Robbins e Cotran. 2006. Le Basi Patologiche delle Malattie (7a edizione), Torino, Elsevier, 2006.

Rollin S, Lemieux C, Maliba R, et al. 2004. VEGF-mediated endothelial P- selectin translocation: role of VEGF receptors and endogenous PAF synthesis. Blood. 103, 3789–97.

Romano MF, Festa M, Pagliuca G, Lerose R, Bisogni R, Chiurazzi F, et al, 2003. BAG3 protein controls B-chronic lymphocytic leukaemia cell apoptosis. Cell Death Differ. 10, 383-5.

Rosati A, Ammirante M, Gentilella A, Basile A, Festa M, Pascale M, et al. 2007. Apoptosis inihibition in cancer cells: a novel molecular pathway that involves BAG3 protein. Int J Biochem Cell Biol. 39, 1337-42.

Rosati A, Basile A, D'Auria R, d'Avenia M, De Marco M, Falco A, Festa M, Guerriero L, Iorio V, Parente R, Pascale M, Marzullo L, Franco R, Arra C, Barbieri A, Rea D, Menichini G, Hahne M, Bijlsma M, Barcaroli D, Sala G, di Mola FF, di Sebastiano P, Todoric J, Antonucci L, Corvest V, Jawhari A, Firpo MA, Tuveson DA, Capunzo M, Karin M, De Laurenzi V, Turco MC. 2015. BAG3 promotes pancreatic ductal adenocarcinoma growth by activating stromal macrophages. Nat Commun. 6, 8695.

Rosati A, Bersani S, Tavano F, Dalla Pozza E, De Marco M, Palmieri M, et al. 2012. Expression of the antiapoptotic protein BAG3 is a feature of pancreatic adenocarcinoma and its overexpression is associated with poorer survival. Am J Path. 181, 1524-29.

Rosati A, Graziano V, De Laurenzi V, Pascale M, Turco MC. 2011. BAG3: a multifaceted protein that regulates major cell pathways. Cell Death and Disease. 2. e141.

Bibliografia

Rosati A, Khalili K, Deshmane SL, Radhakrishnan S, Pascale M, Turco MC, et al. 2009. BAG3 protein regulates caspase-3 activation in HIV-1-infected human primary microglial cells. J Cell Physiol. 218. 264–267.

Siddhartha Jaiswall, Mark P. Chao, Ravindra Majeti and Irving L. Weissman. 2010. Macrophages as mediators of tumor immunosurveillance, Trends in Immunology, 31:212-219.

Sica A, Bronte V. 2007. Altered macrophage differentiation and immune dysfunction in tumor development. J Clin Invest. 117(5):1155-66.

Soker S, Miao HQ, Nomi M, et al. 2002. VEGF165 mediates formation of complexes containing VEGFR-2 and neuropiln-1 that enhance VEGF-165-receptor binding. J Cell Biochem. 85, 357–68.

Soker S, Takashima S, Miao HQ, et al. 1998. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell. 92, 735–45.

Takayama S, Xie Z, Reed JC. 1999. An evolutionarily conserved family of Hsp70/Hsc70 molecular chaperone regulators. J Biol Chem. 274, 781-786.

Tamagnone L, Artigiani S, Chen H, et al. 1999. Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates. Cell. 99, 71–80.

Tisty TD, Coussens LM. 2006. Tumor stroma and regulation of cancer development. Annu Rev Pathol, 1, 119-50.

Van Kempen LC, de Visser KE, Coussens LM. 2006. Inflammation, proteases and cancer. Eur J Cancer. 42(6), 728-34.

Wang Z, Thurmond DC. 2009. Mechanisms of biphasic insulin-granule exocytosis- roles of the cytoskeleton, small GTPases and SNARE proteins. J Cell Sci. 122, 893–903.

Wee Y S, Roundy K M, Weis J J & Weis J H. 2012. Interferon-inducible transmembrane proteins of the innate immune response act as membrane organizers by influencing clathrin and v-ATPase localization and function. Innate Immun. 18, 834-845.

Young P, Anderton E, Paschos K, White R, Allday MJ. 2008. Epstein-Barr virus nuclear antigen (EBNA) 3A induces the expression of and interacts with a subset of chaperones and co-chaperones. J Gen Virol. 89, 866–77.